Mangoceuticals, Inc. MGRX

What this company does

The company connects consumers to licensed healthcare professionals through its website at www.MangoRX.com, for the provision of care via telehealth on its customer portal, and also focuses on developing, marketing, and selling a variety of men's wellness products and services via a telemedicine platform. It has developed and is commercially marketing a brand of ED products under the brand name "Mango," a brand of hair loss products under the brand name "Grow," a brand of hormone balance and therapy products under the name "Mojo," and a brand of weight loss products under the brand name "Slim." All Compounded Products are produced at and fulfilled by Epiq Scripts, LLC, a related party compounding pharmacy, 52% owned by Jacob Cohen, the company's Chief Executive Officer and Chairman, and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. The company's Mango ED product has not been, and will not be, approved by the FDA, and instead the company produces and sells its products under an exemption provided by Section 503A of the Federal Food, Drug and Cosmetic Act. Mango GROW currently includes Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), each of which is used in FDA approved drugs, as well as Vitamin D3 and Biotin, which are available as dietary supplements. SLIM currently includes Vitamin B6, which is available as a dietary supplement, and Semaglutide, the active ingredient used in an FDA approved drug.

Written from the business description in Mangoceuticals, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 1 April 2026. Every sentence was checked against that document before publication.